---
title: CV
author: ~
date: '2017-06-09'
slug: cv
categories: [about]
tags: [CV, about]
banner: 'banners/cv.jpg'
description: 'CV'
images: []
menu: 'main'
weight: 2
---

[CV PDF](https://shanmdphd.github.io/cv/cv-shan.pdf)

<!--more-->


EDUCATION
=========

**M.D.** 2007 - 2015
*School of Medicine, Pusan National University* Pusan, Korea

-   [Physician-Scientist Training Program (full tuition and a stipend)](http://www.nrf.re.kr/biz/info/info/view?biz_no=204)

**Ph.D., Molecular Cell Biology and Genetics** 2009 - 2013
*School of Medicine, Pusan National University* Pusan, Korea

-   Thesis: [Sungpil Han (2012) *Comprehensive Flow Cytometric Immunophenotyping of Peripheral Blood and Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases*](http://academic.naver.com/view.nhn?doc_id=153327918&dir_id=0&field=0&unFold=false&gk_adt=0&sort=0&qvt=1&gk_qvt=0&citedSearch=false&page.page=1&ndsCategoryId=10601)
-   Dissertation research performed through NIH Graduate Partnership Program, 2010 - 2013
-   Molecular Imaging and Cancer Research Lab, School of Medicine, Pusan National University, 2009 - 2010

**B.S., Electrical Engineering** 2000 - 2007
*College of Engineering, Korea University* Seoul, Korea

-   Exchange Student, Department of Computer Science, University of London, Royal Holloway, United Kingdom 2005 - 2006
-   Military Service at the Korean Air Force, 2002 - 2004

CLINICAL EXPERIENCES
====================

**Resident in Clinical Pharmacology and Therapeutics** Mar 2016 - Present
*Asan Medical Center, University of Ulsan* Seoul, Korea

**Intern** Mar 2015 - Feb 2016
*Asan Medical Center, University of Ulsan* Seoul, Korea

**Clinical and Research Elective in Neuropathology** Feb 2009 - Apr 2009
*School of Medicine, Johns Hopkins University* Baltimore, MD

-   Advisor : Charles Eberhart, M.D./Ph.D. and Eric H. Raabe, M.D./Ph.D.
-   Investigated the developmental relationship between human neural stem cells and pediatric brain tumors

**Clinical Elective in Neurosurgery and Pathology** Aug.2008
*School of Medicine, Kyushu University* Fukuoka, Japan

CLINICAL TRIALS INVOLVED
========================

| Duration            | Role       | Study | Therapeutic area/Phase                                                       |
|:--------------------|:-----------|:------|:-----------------------------------------------------------------------------|
| Jul 2017 -          | Sub-I      | SIT   | CPT/Phase I (Dermal fibrosis treatment drug)                                 |
| Mar 2017 -          | Sub-I      | SIT   | CPT/Phase I (GH deficiency treatment drug)                                   |
| Feb 2017 -          | Sub-I      | SIT   | CPT/Phase I (Osteoporosis treatment drug)                                    |
| Feb 2017 -          | Sub-I      | IIT   | CPT/Retrospective (Vancomycin TDM)                                           |
| Jan 2017 -          | Sub-I      | SIT   | CPT/Phase I (BPH treatment drug)                                             |
| Aug 2016 -          | Sub-I      | SIT   | CPT/Phase I (Tuberculosis treatment drug)                                    |
| Apr 2016 -          | Sub-I      | SIT   | CPT/Phase I (BPH treatment drug)                                             |
| Mar 2016 -          | Sub-I      | SIT   | CPT/Phase I (Endometriosis treatment drug)                                   |
| Mar 2016 -          | Sub-I      | SIT   | CPT/Phase I (Osteoporosis treatment drug)                                    |
| Mar 2016 -          | Sub-I      | SIT   | CPT/Phase I (Anti-platelet agent)                                            |
| Mar 2010 - Dec 2012 | Researcher | IIT   | NR/Phase I (Zinbryta$\\textsuperscript{\\textregistered}$, MS treatment mAb) |

RESEARCH EXPERIENCES
====================

**Sub-Investigator** Mar 2016 - Present
*Asan Medical Center, University of Ulsan* Seoul, Korea

-   Advisor: Kyun-Seop Bae, M.D.,Ph.D., Hyeong-Suk Lim, M.D.,Ph.D.
-   Plan, conduct, and report clinical trials
-   Develop statistical softwares using R
-   Perform population modeling and simulation, and design model-based drug development

**Predoctoral Fellow** Jan 2010 - Dec 2012
*Neuroimmunology branch, NINDS, National Institutes of Health* Bethesda, MD

-   Advisor: Bibiana Bielekova, M.D.
-   Participated in phase I clinical trial of DAC HYP for multiple sclerosis patients (Anti-IL-2-receptor alpha chain antibody : Biogen Idec, Inc.)
-   Investigated the mechanism of action of DAC HYP by observing surface cell phenotype, cell signaling, microarray data, and transcription factors
-   Probed the immune response in MS patients' cerebrospinal fluid(CSF) by means of 12-color flow cytometry technique

**Research Assistant** Jan 2009 - Dec 2009
*Pusan National University, School of Medicine* Pusan, Korea

-   Advisor: Saeock Oh, M.D., Ph.D.
-   Investigated a role of Epithelial-Mesenchymal Transition(EMT)-related transcription factor, Snai1 in metastastic potential of glioblastoma multiforme

[PUBLICATIONS](https://scholar.google.com/citations?user=TUK927cAAAAJ&hl=en)
============================================================================

Waters, R. S, J. S. A. Perry, S. Han, B. Bielekova and T. Gedeon (2017). "The effects of interleukin-2 on immune response regulation". Eng. In: *Mathematical medicine and biology : a journal of the IMA*. ISSN: 1477-8602. DOI: [10.1093/imammb/dqw021](http://dx.doi.org/10.1093/imammb/dqw021). PMID: [28339682](http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&cmd=prlinks&retmode=ref&id=28339682).

Han, S, Y. C. Lin, T. Wu, A. D. Salgado, I. Mexhitaj, S. C. Wuest, E. Romm, J. Ohayon, R. Goldbach-Mansky, A. Vanderver, A. Marques, C. Toro, P. Williamson, I. Cortese and B. Bielekova (2014). "Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases". Eng. In: *Journal of immunology (Baltimore, Md. : 1950)* 192.6, pp. 2551-63. ISSN: 1550-6606. DOI: [10.4049/jimmunol.1302884](http://dx.doi.org/10.4049/jimmunol.1302884). PMID: [24510966](http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&cmd=prlinks&retmode=ref&id=24510966).

Perry, J. S. A, S. Han, Q. Xu, M. L. Herman, L. B. Kennedy, G. Csako and B. Bielekova (2012). "Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis". Eng. In: *Science translational medicine* 4.145, p. 145ra106. ISSN: 1946-6242. DOI: [10.1126/scitranslmed.3004140](http://dx.doi.org/10.1126/scitranslmed.3004140). PMID: [22855463](http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&cmd=prlinks&retmode=ref&id=22855463).

Wuest, S. C, J. H. Edwan, J. F. Martin, S. Han, J. S. A. Perry, C. M. Cartagena, E. Matsuura, D. Maric, T. A. Waldmann and B. Bielekova (2011). "A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy". Eng. In: *Nature medicine* 17.5, pp. 604-9. ISSN: 1546-170X. DOI: [10.1038/nm.2365](http://dx.doi.org/10.1038/nm.2365). PMID: [21532597](http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&cmd=prlinks&retmode=ref&id=21532597).

Han, S, J. Kim, M. Han, H. Sim, K. Kim, S. Yoon, S. Baek, B. Kim and S. Oh (2011). "SNAI1 is involved in the proliferation and migration of glioblastoma cells". Eng. In: *Cellular and molecular neurobiology* 31.3, pp. 489-96. ISSN: 1573-6830. DOI: [10.1007/s10571-010-9643-4](http://dx.doi.org/10.1007/s10571-010-9643-4). PMID: [21225336](http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&cmd=prlinks&retmode=ref&id=21225336).

PUBLISHED PROCEEDINGS
=====================

Han, S, Y. Kim, H. Y. Choi, D. Soh, J. Kim, J. Nam, J. Kim, K. Bae and H. Lim (2017). "Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, A Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers". In: *Clinical Therapeutics* 39.8, p. e48. DOI: [10.1016/j.clinthera.2017.05.148](http://dx.doi.org/10.1016/j.clinthera.2017.05.148).

Han, S, H. Y. Choi, Y. H. Kim, W. J. Kim, K. Bae and H. Lim (2017). "Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, Recently Developed Bivalirudin". In: *Clinical Therapeutics* 39.8, p. e54. DOI: [10.1016/j.clinthera.2017.05.169](http://dx.doi.org/10.1016/j.clinthera.2017.05.169).

Han, S, H. Y. Choi, Y. H. Kim, J. Y. Nam, G. S. Song, H. Lim and K. Bae (2017). "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Oral Doses of CJ-12420 (Tegoprazan), A Novel Potassium-Competitive Acid Blocker (P-CAB) in Healthy Male Subjects". In: *Clinical Therapeutics* 39.8, pp. e97-e98. DOI: [10.1016/j.clinthera.2017.05.306](http://dx.doi.org/10.1016/j.clinthera.2017.05.306).

Han, S, K. Lim, S. Cho, J. Kim, S. Choe, J. Jung, J. Ghim, H. Jeong, T. Yoo, S. Kim and others (2016). "Effects of single oral administration of SKI2670, gonadotropin-releasing hormone (GnRH) antagonist, in healthy pre-menopausal women". In: *Fertility and Sterility* 106.3, p. e273. DOI: [10.1016/j.fertnstert.2016.07.785](http://dx.doi.org/10.1016/j.fertnstert.2016.07.785).

Han, S, A. D. Salgado, E. Romm and B. Bielekova (2012). "Comprehensive monitoring of intrathecal immune cells in patients with multiple sclerosis by 12-color flow cytometric immunophenotyping". In: *Journal of Neuroimmunology* 253.1-2, pp. 98-98. DOI: [10.1016/j.jneuroim.2012.10.001](http://dx.doi.org/10.1016/j.jneuroim.2012.10.001).

Han, S, J. S. Perry, Q. Xu, L. B. Kennedy and B. Bielekova (2012). "Inhibitory effects of CD25 blockade on development of pro-inflammatory innate lymphoid cells is associated with decreased intrathecal inflammation in MS". In: *Journal of Neuroimmunology* 253.1-2, pp. 67-67. DOI: [10.1016/j.jneuroim.2012.10.001](http://dx.doi.org/10.1016/j.jneuroim.2012.10.001).

Han, S, A. Salgado, T. Alfahad and B. Bielekova (2012). "Flow Cytometric Immunophenotyping of the Blood and CSF of Patients with Multiple Sclerosis". In: *Neurology* 78.1 Supplement, pp. P02-081.

Wuest, S, S. Han, J. Martin, D. Maric and B. Bielekova (2011). "Daclizumab Inhibits Expansion of Antigen (Ag)-Specific T Cells by Blocking IL-2 Transpresentation by Dendritic Cells". In: *Neurology* 76.9, pp. A240-A240.

Han, S, I. Cortese and B. Bielekova "Effects of Long-Term (&gt; 5 Years) Daclizumab Therapy on Lymphocyte Subpopulations - Comparison of Immediate Ex-Vivo Immunophenotyping with Commercially-Available Assay". English. In: *NEUROLOGY* 76.9, 4. 63rd AAN Annual Meeting, Honolulu, HI, APR 09-16, 2011, pp. A239-A240. ISSN: 0028-3878.

Perry, J, S. Han, L. B. Kennedy and B. Bielekova "Opposing regulation between lymphoid tissue inducer cells and immunoregulatory CD56bright NK cells underlies therapeutic benefit of daclizumab in MS". English. In: *JOURNAL OF NEUROIMMUNOLOGY* 228.1-2, SI. 10th Congress of the International-Society-of-Neuroimmunology (ISNI), Sitges, SPAIN, OCT 26-30, 2010, pp. 111-112. ISSN: 0165-5728. DOI: [10.1016/j.jneuroim.2010.08.001](http://dx.doi.org/10.1016/j.jneuroim.2010.08.001).

OTHER PROCEEDINGS
=================

Sungpil Han (2016), First-in-human Study Assessing Safety, Tolerability, and Pharmacokinetics of JPI-289, a Novel Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor in Healthy Male Volunteers, Korean Society of Clinical Pharmacology and Therapeutics Fall Symposium, 2016, Jeonju, Korea

Simone Wuest, SungPil Han, Jayne Martin, Dragan Maric, Bibiana Bielekova (2011) "Anti-CD25 Antibody Inhibits Antigen-specific T cell Expansion by Blocking IL-2 Transpresentation by Dendritic Cells", Federation of Clinical Immunology Societies 2011, Washington DC

Justin Perry, SungPil Han, Lucy Kennedy, Bibiana Bielekova (2011) "Opposing Developmental Regulation Between Lymphoid Tissue Inducer Cells and Immunoregulatory CD56bright NK Cells Contributes to Therapeutic Benefit of Daclizumab in Multiple Sclerosis", Federation of Clinical Immunology Societies 2011, Washington DC

SungPil Han, Justin Perry, Kory Johnson, Bibiana Bielekova (2011) "Signaling Though High- versus Intermediate-affinity Interleukin-2 (IL-2) Receptor Provides Qualitatively Different Signals to T cells", Annual conference of National Institute of Neurological Disorders and Stroke 2011, VA

Simone Wuest, Jayne Martin, SungPil Han, Justin Perry, Thomas Waldmann, Bibiana Bielekova (2011) "Important role for IL-2 transpresentation in the induction of antigen-specific T cell responses by dendritic cells.", Keystone Symposia on Molecular and Cellular Biology: Dendritic cells and the initiation of adaptive immunity. Santa Fe, NM

SungPil Han, Bibiana Bielekova (2010) "Comprehensive investigation of the mechanism of action of CD25-blocking Ab DAC-HYP in multiple sclerosis", Annual Bioscience and Engineering Symposium 2010, Bethesda, MD

ACADEMIC PRESENTATIONS
======================

**The 13<sup>th</sup> Congress of EACPT** Prague, Czech | Jun 2017
Young Clinical Pharmacologists Session: *Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, a Novel Poly (ADP-ribose) Polymerase-1 Inhibitor in First-in-human Study of Healthy Volunteers*

**Expert Meeting, KFDA** Seoul, Korea | Apr 2017
*ICH E18: Guideline on Genomic Sampling and Management of Genomic Data*

**EDISON Conference 2017** Daejeon, Korea | Mar 2017
*Monte Carlo Simulation of Plasma Caffeine Concentration by Using Population Pharmacokinetic Model*

**Korean Society of Clinical Pharmacology and Therapeutics Symposium** Jeonju, Korea | Oct 2016
*Effects of Single Oral Administration of SKI2670, Gonadotropin-releasing Hormone (GnRH) Antagonist: A Randomized, Double-blind, Placebo-controlled, First-in-human Study in Healthy Pre-menopausal Women*

**NIH Neuroimmunology Branch Seminar** Bethesda, MD | 2012
*Comprehensive Investigation of Mechanism of Action of DAC HYP in Patients with Multiple Sclerosis*

**Annual Bioscience and Engineering Symposium** Vienna, VA | Nov 2011
*Neuroimmunological findings from patients with multiple sclerosis by flow cytometric immunophenotyping of cerebrospinal fluid and blood*

**NIH Neuroimmunology Branch Seminar** Bethesda, MD | Jun 2011
*Immunological findings from DAC HYP Clinical Trial (10-N-0125): Comprehensive ex vivo investigation of DAC HYP in MS patients*

**PNU Research Festival** Gyeongju, Korea | Dec 2009
*Genome-wide identification of Gli3 direct target genes during neurodevelopment*

STATISTICAL SOFTWARES
=====================

Han, S. (2017a). *caffsim: Simulation of Plasma Caffeine Concentrations by Using Population Pharmacokinetic Model*. R package version 0.2.3. URL: <https://github.com/asancpt/caffsim>.

Han, S. (2017b). *crftools: Tools for Creating, Editing, and Managing Case Report Forms of AsanCPT*. R package version 0.3.1. URL: <https://github.com/asancpt/crftools>.

Han, S. (2017c). *glasgowcoma: A Reference of Glasgow Coma Scale*. R package version 0.0.1. URL: <https://github.com/shanmdphd/glasgowcoma>.

Han, S. (2017) *pkrshiny: Noncompartmental Analysis using pkr R package* Shiny application. URL: <https://asan.shinyapps.io/pkrshiny>

Han, S. (2016) *vtdm: Vancomycin TDM* Shiny application. URL: <https://asan.shinyapps.io/vtdm>

Han, S. (2016) *caff: Monte Carlo Simulation of Caffeine* Shiny application. URL: <https://asan.shinyapps.io/caff>

Han, S. (2016) *noncompart: Noncompartmental Analysis using noncompart R package* Shiny application. URL: <https://asan.shinyapps.io/noncompart>

GRANTS AND AWARDS
=================

**Research Prize of EDISON Conference 2017** 2017
*Minister of Ministry of Science, ICT and Future Planning* Daejeon, Korea

**Outstanding Research Abstract** 2016
*KSCPT* Seoul, Korea

**Outstanding Resident of Asan Global Standard** 2016
*Asan Medical Center* Seoul, Korea

**Physician-Scientist Training Program Fellowship** 2008 - 2015
*National Research Foundation, Korea* Daejeon, Korea

**Intramural Research Fellowship** 2010 - 2012
*National Institutes of Health* Bethesda, MD

**Travel Award** 2011
*Annual Bioscience and Engineering Symposium* Bethesda, MD

**Hanmi Travel Award** 2011
*Baltimore/Washington Metropolitan Area Life Science Association (BLSA)* Bethesda, MD

**Global Internship Fellowship** 2010
*National Research Foundation, Korea - Brain Korea 21*

**Graduate Student Fellowship** 2007, 2008
*National Research Foundation, Korea - Brain Korea 21*

**Scholarship of Academic Achievement** 2007, 2008
*Pusan National University*

**Scholarship for Exchange Student to University of London** 2005, 2006
*Korea University*

**Scholarship of Academic Achievement** 2001
*Korea University*

TEACHING EXPERIENCE
===================

**Lecturer and Teaching Assistant** Spring 2017
*College of Medicine, University of Ulsan* Seoul, Korea

-   [WA5493: R Programming](https://asancpt.github.io/Rprogramming)

**Lecturer and Mentor** Summer 2016, 2017
*College of Medicine, University of Ulsan* Seoul, Korea

-   [Clinical Elective in Clinical Pharmacology, Asan Medical Center](https://github.com/asancpt/subintern)

**Lecturer and Mentor** Summer 2010, 2011, 2012
*NINDS, National Institutes of Health* Bethesda, MD

-   Mentoring college students for the summer through NINDS Summer Internship
-   *Comprehensive Investigation on Mechanism of CD25-blocking Antibody in human*

**Lecturer and Mentor** Spring, Fall, 2009
*School of Medicine, Pusan National University* Pusan, Korea

-   Mentoring Jangyoungsil Science High School students through "Creativity" Project, National Research Foundation of Korea
-   *Mechanism of Action of siRNA*

SCIENTIFIC SOCIETY AND CONSORTIA MEMBERSHIP
===========================================

**Member** 2017 - Present
*European Association of Clinical Pharmacology and Therapeutics (EACPT)*

**Member** 2016 - Present
*Population Approach Group in Korea (PAGK)*

**Member** 2016 - Present
*Korean Society of Clinical Pharmacology and Therapeutics (KSCPT)*

**Member** 2016 - Present
*The Korean Society for Reproductive Medicine*

**Member** 2011 - Present
*Federation of Clinical Immunology Societies (FOCIS)*

**Member** 2010 - Present
*American Academy of Neurology (AAN)*

**Member** 2010 - Present
*Korean-American Scientists and Engineers Association (KSEA)*

REFERENCES
==========

**Professor Kyun-Seop Bae, M.D., Ph.D.**
Chief of Department of Clinical Pharmacology of Therapeutics
Asan Medical Center, Seoul, School of Medicine, University of Ulsan
Tel : +82-2-3010-4645, E-mail : <ksbae@acp.kr>

**Professor Hyeong-seok Lim, M.D., Ph.D.**
Department of Clinical Pharmacology of Therapeutics
Asan Medical Center, Seoul, School of Medicine, University of Ulsan
Tel : +82-2-3010-4613, E-mail : <mdlhs@amc.seoul.kr>

**Investigator Bibiana Bielekova, M.D.**
Chief of Neuroimmunological Diseases Unit(NDU)
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Tel : (301) 402-4488, E-mail : <Bibi.Bielekova@nih.gov>

**Professor Charles G. Eberhart, M.D./Ph.D.**
Associate Professor of Departments of Pathology, Ophthalmology, and Oncology
Johns Hopkins University School of Medicine
Tel : (410) 955-3455, E-mail : <ceberha@jhmi.edu>

**Professor Saeock Oh, M.D., Ph.D.**
Associate professor of Department of Anatomy
School of Medicine, Pusan National University, Mulgeum-Eup, Beomeo-Ri, Yangsan, South Korea 626770
Tel : +82-51-510-8045, E-mail : <hedgehog@pusan.ac.kr>

The up-to-date CV is available [here](https://shanmdphd.github.io/cv/cv-shan.pdf).
